NYSE:RCOR Renovacor (RCOR) Stock Price, News & Analysis → A new way to collect income from stocks (From DTI) (Ad) Free RCOR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$3.20▼$3.2050-Day Range$2.56▼$3.2852-Week Range$1.34▼$9.74VolumeN/AAverage Volume30,033 shsMarket Capitalization$55.26 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Renovacor alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About Renovacor Stock (NYSE:RCOR)Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). The company's lead product candidate is REN-001, a recombinant adeno-associated virus 9-based gene therapy designed to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes, and slow or halt progression of BAG3 DCM. It is also developing a pipeline of BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function. The company was founded in 2013 and is based in Greenwich, Connecticut.Read More Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. RCOR Stock News HeadlinesApril 22, 2024 | cnet.comRecord Store Day 2024: How to Flatten Warped Vinyl Records at HomeOctober 24, 2023 | nypost.comNYC shoplifting hit record highs last year: ‘We can’t stop them’April 23, 2024 | Whats On Finance (Ad)Putin and other countries have a planDid you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. October 17, 2023 | finance.yahoo.comRockwell Medical Appoints Joan Lau, Ph.D. to the Company's Board of DirectorsOctober 3, 2023 | nypost.comHere’s why you shouldn’t record meltdowns on an airplane: FAA insiderSeptember 28, 2023 | washingtonpost.comRecord-breaking heat wave peaking in Eastern U.S. with highs near 100September 15, 2023 | macrumors.comiOS 17: How to Record a FaceTime Video or Audio MessageSeptember 9, 2023 | washingtonpost.comThis was the world’s hottest summer on record ‘by a large margin’April 23, 2024 | Whats On Finance (Ad)Putin and other countries have a planDid you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. August 23, 2023 | forbes.comRecord-Breaking Summer: Portland, New Orleans Break Daily High Temperature Records After Hottest July EverAugust 16, 2023 | forbes.comRecord-Breaking Summer: Jacksonville, Miami Break Daily High Temperature Records, After Hottest July EverAugust 11, 2023 | forbes.comPhoenix, New Orleans, Baton Rouge Break Daily High Temperature Records: Here’s Where Else Daily Records Have FallenAugust 9, 2023 | forbes.comPhoenix, Dallas, Little Rock Break Daily High Temperature Records: Here’s Where Else Daily Records Have FallenAugust 5, 2023 | washingtonpost.comPhoenix just posted the hottest month ever observed in a U.S. cityJuly 20, 2023 | forbes.comPhoenix, Salt Lake City Set High Temperature Records: Here’s Where Else Records Could FallFebruary 10, 2023 | benzinga.comMobile Global Esports Stock (NASDAQ:MGAM), Quotes and News SummaryNovember 16, 2022 | markets.businessinsider.comRobert W. Baird Keeps Their Hold Rating on Renovacor (RCOR)October 20, 2022 | prnewswire.comRENOVACOR INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Renovacor, Inc. - RCOROctober 15, 2022 | benzinga.comLifshitz Law PLLC Announces Investigations of FCRD, POSH, LOGC, and RCOROctober 10, 2022 | finance.yahoo.comRenovacor Announces Upcoming Presentation at the 29th European Society of Gene & Cell Therapy CongressSeptember 28, 2022 | benzinga.comRenovacor Announces Upcoming Presentation at...September 26, 2022 | finance.yahoo.comRenovacor Announces Upcoming Presentation at Keystone Symposia’s Heart Failure: Mechanisms and Therapies ConferenceSeptember 24, 2022 | benzinga.comLifshitz Law PLLC Announces Investigations of RCKT, STOR, RCOR, and OCSLSeptember 20, 2022 | bizjournals.comTemple University biotech spinout Renovacor acquired for $53MSeptember 20, 2022 | benzinga.comSHAREHOLDER ALERT: Weiss Law Investigates Renovacor, Inc.September 20, 2022 | bizjournals.comCambridge biotech acquired for $53M following move from PhiladelphiaSeptember 15, 2022 | uk.investing.comWhy SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day SessionSee More Headlines Receive RCOR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Renovacor and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolNYSE:RCOR CUSIPN/A CIK1799850 Webrenovacor.com Phone610-424-2650FaxN/AEmployees19Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.73) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-14,100,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-62.88% Return on Assets-48.90% Debt Debt-to-Equity RatioN/A Current Ratio6.60 Quick Ratio6.60 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.47 per share Price / Book1.30Miscellaneous Outstanding Shares17,269,000Free Float14,782,000Market Cap$55.26 million OptionableNot Optionable Beta-0.28 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Magdalene K. Cook M.D.Chairman, Pres & CEODr. Matthew Killeen Ph.D. (Age 39)Chief Scientific Officer Comp: $404.03kDr. Marc Semigran M.D. (Age 65)Chief Medical Officer Comp: $585.7kDr. Arthur Michael Feldman M.D.Ph.D., Founder & Member of Scientific Advisory BoardMs. Wendy F. DiCicco CPA (Age 55)CPA, CFO & Principal Financial Officer Dr. Elizabeth White Ph.D.Chief Bus. Officer & Sr. VP of OperationsMr. Joseph CarrollSr. VP, Chief Accounting Officer & Corp. Sec.Dr. Jiwen Zhang Ph.D.Chief Regulatory OfficerDr. Jordan Shin M.D.Ph.D., Sr. VP of Clinical Devel. & Translational ScienceDr. Kumar Dhanasekharan Ph.D.Sr. VP of Technical OperationsMore ExecutivesKey CompetitorsAVROBIONASDAQ:AVROJATT AcquisitionNYSE:JATTGenenta ScienceNASDAQ:GNTAIkena OncologyNASDAQ:IKNAEntera BioNASDAQ:ENTXView All Competitors This page (NYSE:RCOR) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Renovacor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
